SOFT TISSUE SARCOMAS
Clinical trials for SOFT TISSUE SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMAS trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets rare sarcomas with gene mutations
Disease control Recruiting nowThis early-phase trial tests a combination of two drugs, gemcitabine and nab-sirolimus, in people with advanced leiomyosarcoma or other soft-tissue sarcomas that have lost function in the TSC1 or TSC2 genes. The main goal is to find a safe dose and watch for side effects. Up to 1…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
New hope for rare sarcomas: immune drug plus chemo tested
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy can help shrink or control advanced soft tissue sarcomas that cannot be removed by surgery. About 45 adults aged 18-75 with certain sarcoma types will receive the combination as their fir…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Gene signature may guide sarcoma treatment
Knowledge-focused Recruiting nowThis study is for people with soft-tissue sarcoma who are scheduled for chemotherapy before surgery. Researchers want to see if a genetic marker called CINSARC can predict how well the chemotherapy works. About 205 participants will provide tumor samples and be followed during tr…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 26, 2026 06:59 UTC